Sanofi Pasteur partners with US Navel Medical Research Center

Sanofi Pasteur has entered into a strategic partnership with the US Naval Medical Research Center to develop a bacterial vaccine against enterotoxigenic Escherichia coli, a cause of infectious gastroenteritis in travellers.